Securities Registration: Employee Benefit Plan (s-8)
15 Mars 2023 - 10:02PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission
on March 15, 2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under
The Securities Act of 1933
908 DEVICES INC.
(Exact name of registrant as specified in its
charter)
|
|
|
Delaware |
|
45-4524096 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification Number) |
645 Summer Street
Boston, MA 02210
(857) 254-1500
(Address of Principal Executive Offices)
908 Devices Inc. 2020 Stock Option and Incentive
Plan
908 Devices Inc. 2020 Employee Stock Purchase
Plan
(Full Title of the Plans)
Kevin J. Knopp
Chief Executive Officer
645 Summer Street
Boston, MA 02210
(857) 254-1500
(Name, address, including
zip code, and telephone number, including area code, of agent for service)
Copies to:
Mark J. Macenka
Michael J. Minahan
Goodwin Procter LLP
100 Northern Ave.
Boston, MA 02210
(617) 570-1000
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth
company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
¨ |
|
Accelerated filer |
|
¨ |
|
|
|
|
Non-accelerated filer |
|
x |
|
Smaller reporting company |
|
x |
|
|
|
|
|
|
|
|
Emerging growth company |
|
x |
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
EXPLANATORY NOTE
This Registration Statement on Form S-8 registers
(i) an additional 1,274,394 shares of the Registrant’s common stock, $0.001 par value per share (the “Common Stock”),
to be issued under the Registrant’s 2020 Stock Option and Incentive Plan (the “2020 Plan”) and (ii) an additional
307,295 shares of the Common Stock to be issued under the Registrant’s 2020 Employee Stock Purchase Plan (the “2020 ESPP”).
The number of shares of Common Stock reserved and available for issuance under the 2020 Plan is subject to an automatic annual increase
on each January 1, beginning in 2022, by an amount equal to the lesser of: (i) four percent (4%) of the number of shares of
Common Stock issued and outstanding on the immediately preceding December 31st, or (ii) such number of shares of Common Stock
as determined by the Administrator (as defined in the 2020 Plan). Shares available for issuance under the 2020 Plan were previously registered
on Form S-8 filed with the Securities and Exchange Commission on December 28, 2020 (Registration No. 333-251755) and Form S-8 filed with the Securities and Exchange Commission on March 11, 2022 (Registration No. 333-263485) (collectively, the “Registration
Statement”). The number of shares of Common Stock reserved and available for issuance under the 2020 ESPP is subject to an automatic
annual increase on each January 1, beginning in 2022, by an amount equal to the lesser of: (i) 307,295 shares of Common Stock,
(ii) one percent (1%) of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st,
or (iii) such number of shares of Common Stock as determined by the Administrator (as defined in the 2020 ESPP). Shares available
for issuance under the 2020 ESPP were previously registered on the Registration Statement. The information contained in the Registration
Statement related to the 2020 Plan and the 2020 ESPP is hereby incorporated by reference pursuant to General Instruction E.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
See the Exhibit Index below for a list of exhibits filed as part
of this registration statement on Form S-8, which Exhibit Index is incorporated herein by reference.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Act, as amended, the
registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston,
State of Massachusetts, on the 15th day of March, 2023.
|
908 DEVICES INC. |
|
|
|
|
|
By: |
/s/ Kevin J. Knopp, Ph.D. |
|
|
Kevin J. Knopp, Ph.D. |
|
|
Chief Executive Officer and Director |
POWER OF ATTORNEY AND SIGNATURES
KNOW ALL BY THESE PRESENT, that each individual whose signature appears
below hereby constitutes and appoints Kevin J. Knopp, Ph.D., who may act without the joinder of the other, as his or her true and lawful
attorneys-in-fact and agents with full power of substitution and resubstitution, for him or her and in his or her name, place and stead,
in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8,
and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission
granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby
ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully
do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, as amended, this
Registration Statement has been signed by the following persons in the capacities and on the date indicated below.
Name |
Title |
Date |
|
|
|
/s/ Kevin J.
Knopp, Ph.D.
Kevin J. Knopp, Ph.D. |
Chief Executive Officer and Director (Principal Executive Officer) |
March 15, 2023 |
|
|
|
/s/ Joseph H.
Griffith IV
Joseph H. Griffith IV |
Chief Financial Officer (Principal Financial and Accounting Officer) |
March 15, 2023 |
|
|
|
/s/ Keith L.
Crandell
Keith L. Crandell |
Director |
March 15, 2023 |
|
|
|
/s/ Marcia Eisenberg,
Ph.D.
Marcia Eisenberg, Ph.D. |
Director |
March 15, 2023 |
|
|
|
/s/ Fenel M.
Eloi
Fenel M. Eloi |
Director |
March 15, 2023 |
|
|
|
/s/ Jeffrey
P. George |
Director |
March 15, 2023 |
Jeffrey P. George |
|
|
|
|
|
/s/ Tony J. Hunt |
Director |
March 15, 2023 |
Tony J. Hunt |
|
|
/s/ E. Kevin Hrusovksy
|
Director |
March 15, 2023 |
E. Kevin Hrusovksy |
|
|
|
|
|
/s/ Mark Spoto
Mark Spoto |
Director |
March 15, 2023 |
908 Devices (NASDAQ:MASS)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
908 Devices (NASDAQ:MASS)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025